Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 17;11:677983. doi: 10.3389/fonc.2021.677983

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Sesti, Feola, Puliani, Centello, Di Vito, Bagni, Lenzi, Isidori, Cantisani, Faggiano and Giannetta

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Functional imaging of right and left paraganglioma and response to sunitinib treatment assesed by PERCIST criteria. (A) 18F-fluoro-dihydroxyphenylalanine (18F-DOPA) positron emission tomography (PET)-computed tomography (CT) in May 2018; (B) 68Ga-DOTA-D-Phe1-Tyr3-Octreotate (68Ga-DOTATOC) PET-CT in October 2018; (C) 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-computed tomography (CT) with contrast medium performed after the third cycle of therapy in June 2020; (D) peak standardized uptake value corrected for lean body mass (SULpeak) trend for the hottest lesion between the two susequent 18F-FDG PET-CT (October 2020 and June 2020).